Invention Grant
- Patent Title: Derivatives of uridine 5′-cyclophosphate useful to treat hepatitis C viral infections
-
Application No.: US15034757Application Date: 2014-11-19
-
Publication No.: US09676809B2Publication Date: 2017-06-13
- Inventor: Lin Zhi
- Applicant: Ligand Pharmaceuticals Incorporated
- Applicant Address: US CA San Diego
- Assignee: Ligand Pharmaceuticals Incorporated
- Current Assignee: Ligand Pharmaceuticals Incorporated
- Current Assignee Address: US CA San Diego
- Agency: Knobbe, Martens, Olson & Bear LLP
- International Application: PCT/US2014/066456 WO 20141119
- International Announcement: WO2015/077368 WO 20150528
- Main IPC: C07H19/10
- IPC: C07H19/10 ; C07H19/11
Abstract:
Some embodiments of the present invention include nucleoside 5′-monophosphate derivative compounds, their preparation and their uses. In some embodiments, such compounds are useful to treat hepatitis C viral infections.
Public/Granted literature
- US20160347783A1 DERIVATIVES OF URIDINE 5'-CYCLOPHOSPHATE USEFUL TO TREAT HEPATITIS C VIRAL INFECTIONS Public/Granted day:2016-12-01
Information query
IPC分类:
